Health and Fitness Health and Fitness
Fri, August 27, 2010
[ Fri, Aug 27th 2010 ] - Market Wire
Medical Action Industries Inc. Completes Acquisition of AVID Medical, Inc.
[ Fri, Aug 27th 2010 ] - Market Wire
Zynex Announces New ChiefFinancial Officer
[ Fri, Aug 27th 2010 ] - Market Wire
Experienced Financial Executive, Peter Donato, Joins Hythiam as CFO
[ Fri, Aug 27th 2010 ] - Market Wire
HealthSpring, Inc. to Acquire Bravo Health, Inc.
[ Fri, Aug 27th 2010 ] - Market Wire
Genentech Receives Refuse to File Letter from FDA for T-DM1
Thu, August 26, 2010
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis completa la compra a Nestl© de intereses mayoritarios en Alcon
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis conclui compra de participao majoritria da Nestl© na Alcon
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis erwirbt Aktienmehrheit an Alcon von Nestl©
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis achve la?achat de la part majoritaire de Nestl© dans le capital da?Alcon
[ Thu, Aug 26th 2010 ] - Market Wire
The Zacks Small-Cap Profile features Cytori Thera .. iosciences, StemCells and International Stem Cell
[ Thu, Aug 26th 2010 ] - Market Wire
RehabCare to Present at the Morgan Stanley Global Healthcare Conference
[ Thu, Aug 26th 2010 ] - Market Wire
XenoPort Announces Changes to Executive Team
[ Thu, Aug 26th 2010 ] - Market Wire
PATIENT HOME MONITORING ANNOUNCES CHANGE IN FISCAL YEAR-END
[ Thu, Aug 26th 2010 ] - Market Wire
Spectral Molecular Imaging, Inc. Announces Accele .. its Early Melanoma Detection Product SkinSpecta"
[ Thu, Aug 26th 2010 ] - Market Wire
Enzo Biochema?s Clinical Lab Takes Major Step in .. oming National Provider of Predictive Diagnostics
[ Thu, Aug 26th 2010 ] - Market Wire
Health Net, Inc. Mourns the Death of Thomas T. Farley, a Member of Its Board of Directors
[ Thu, Aug 26th 2010 ] - Market Wire
American HomePatient Announces Five Business Day .. lf-Tender Offer and Modification of 90% Condition
[ Thu, Aug 26th 2010 ] - Market Wire
International Stem Cell Corporation Not Adversely Affected by Stem Cell Research Funding Ban
[ Thu, Aug 26th 2010 ] - Market Wire
Medtronic Receives Health Canada Approval for the .. ofrequency Ablation Tools for Atrial Fibrillation
[ Thu, Aug 26th 2010 ] - Market Wire
Medtronic reoit de Sant© Canada la?homologation .. ?ablation de la fibrillation auriculaire par radi
[ Thu, Aug 26th 2010 ] - Market Wire
Celgene Corporation Announces Appointment of Jacq .. Senior Vice President and Chief Financial Officer
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis voltooit aankoop meerderheidsbelang Alcon van Nestl©
[ Thu, Aug 26th 2010 ] - Market Wire
Novartis completa acquisto da Nestl© di interesse di maggioranza su Alcon
Wed, August 25, 2010
[ Wed, Aug 25th 2010 ] - Market Wire
Novartis Completes Purchase from Nestl© of Majority Interest in Alcon
[ Wed, Aug 25th 2010 ] - Market Wire
Medtronic, Boston Scientific, St. Jude Medical, Haemonetics and Cyberonics
[ Wed, Aug 25th 2010 ] - Market Wire
Medtronic Response to Pakistan Flooding Relief Efforts
[ Wed, Aug 25th 2010 ] - Market Wire
PPD Appoints Neil McCullough, Ph.D., Vice President of Quality Management Systems
[ Wed, Aug 25th 2010 ] - Market Wire
The Fourth Product Candidate Containing Antigenics' QS-21 In Phase 3 Clinical Development
[ Wed, Aug 25th 2010 ] - Market Wire
NexMed To Present at the Rodman & Renshaw 12th Annual Healthcare Conference
[ Wed, Aug 25th 2010 ] - Market Wire
Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2011

Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2011


Published on 2010-08-25 06:35:29 - Market Wire
  Print publication without navigation


MINNEAPOLIS--([ BUSINESS WIRE ])--The board of directors of Medtronic, Inc. (NYSE:MDT), today approved a cash dividend of $0.225 per share of the companya™s common stock. The dividend is payable on October 29, 2010, to shareholders of record at the close of business on October 8, 2010.

About Medtronic

Medtronic, Inc. ([ www.medtronic.com ]), headquartered in Minneapolis, is the global leader in medical technology a" alleviating pain, restoring health, and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronica™s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.Medtronic does not undertake to update its forward-looking statements.

Contributing Sources